Endocrine disruptors effect on inflammatory heart disease
内分泌干扰物对炎症性心脏病的影响
基本信息
- 批准号:8765093
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAdultAgeAnaphylatoxinsAnti-Inflammatory AgentsAnti-inflammatoryAtherosclerosisAutoimmune DiseasesAutoimmune ProcessCardiacCardiovascular DiseasesCaspase-1Cause of DeathCell CountClinical ResearchComplement 1 InactivatorsComplement ReceptorDevelopmentDilated CardiomyopathyDiseaseDisease ProgressionDoseEndocrine DisruptorsEndocrine disruptionEnvironmental ExposureEstrogen ReceptorsEstrogensExposure toFemaleFibrosisGenesGoalsGonadal Steroid HormonesHeartHeart DiseasesHeart TransplantationHeart failureHormonesHumanImmune responseImmunologic AdjuvantsIncidenceInflammationInflammatoryInterleukin-1Interleukin-4Knockout MiceLiteratureMediatingMusMyocarditisPathogenesisPublishingReceptor SignalingRegulatory T-LymphocyteReportingResearch PersonnelRiskRoleSeveritiesSudden DeathTLR4 geneTestosteroneWomanbasebisphenol Adrinking waterendocrine disruptor exposurein uteromalemast cellmenmouse modeloffspringprenatal exposurepublic health relevancereceptorreproductiveresearch studysexyoung adult
项目摘要
DESCRIPTION (provided by applicant): The long term goal of this project is to determine the effect of endocrine disruptors (EDs), beginning with bisphenol A (BPA), on auto/inflammatory cardiovascular diseases (iCVDs). Myocarditis is an autoimmune iCVD that leads to dilated cardiomyopathy (DCM) and heart failure (HF) and was listed in a recent Lancet report as the 32nd cause of death globally. Autoinflammatory CVDs including myocarditis, DCM, and atherosclerosis occur predominantly in men, who are at an increased risk of developing DCM and HF. The investigators have previously published that testosterone drives myocarditis by increasing mast cells and by activating the inflammasome (i.e. TLR4, caspase-1 and interleukin (IL)-1), resulting in cardiac remodeling, fibrosis and progression to DCM. In contrast, estrogen (E2) decreases myocarditis in female mice by elevating anti- inflammatory immune responses including IL-4/Th2 and regulatory T cells (Treg). Clinical and experimental studies indicate that E2, via the estrogen receptor (ER), mediates cardio-protection against iCVDs in females, while ER signaling has the opposite effect. Since myocarditis and DCM are strongly influenced by sex hormones, ED exposure in utero or as an adult could influence adult autoimmune CVD. To our knowledge no one has examined the potential effect of EDs on myocarditis or DCM. In preliminary studies presented here, the investigators found that a high human relevant exposure of 25 g/L of BPA administered to adult female mice in drinking water significantly increased myocarditis and converted females to a male-like inflammatory profile. ER was significantly decreased in the heart during myocarditis (using qRT-PCR of the whole heart) at this dose of BPA, while ER was significantly increased compared to controls, indicating BPA disregulation of ER signaling in the heart. Based on these findings and the literature on the cardioprotective role of ER, the investigators hypothesize that BPA increases myocarditis in female mice via ER on mast cells. The investigators will investigate the mechanisms of BPA effects on myocarditis and DCM by determining in Aim 1 whether adult exposure to BPA is acting through ER (or other ERs) to increase myocarditis in adult male and female mice, and in Aim 2 by examining the effect of prenatal exposure to BPA on adult disease in male and female offspring (F1). If BPA is activating mast cells to increase iCVD, this study will have a great impact on the understanding of disease pathogenesis.
描述(由申请人提供):该项目的长期目标是确定内分泌干扰物(EDS)的影响(EDS),以双酚A(BPA)(BPA),对自动/炎症性心血管疾病(ICVD)的影响。心肌炎是一种自身免疫性ICVD,导致心肌病(DCM)和心力衰竭(HF)的扩张,并在最近的柳叶刀报告中被列为全球第32号死亡原因。包括心肌炎,DCM和动脉粥样硬化在内的自身炎症CVD主要发生在患有DCM和HF的风险增加的男性中。研究人员先前已经发表了睾丸激素通过增加肥大细胞并激活炎性体(即TLR4,caspase-1和白介素(IL)-1)来驱动心肌炎,从而导致心脏重塑,纤维化,纤维化和发展为DCM。相反,雌激素(E2)通过升高包括IL-4/TH2和调节T细胞(TREG)在内的抗炎性免疫反应来降低雌性小鼠的心肌炎。临床和实验研究表明,通过雌激素受体(ER)E2介导对女性ICVD的心脏保护,而ER信号传导具有相反的作用。由于心肌炎和DCM受性激素的强烈影响,因此在子宫内或成年人的ED暴露可能会影响成人自身免疫性CVD。据我们所知,没有人检查ED对心肌炎或DCM的潜在影响。在此处介绍的初步研究中,研究人员发现,在饮用水中向成年雌性小鼠施用的25 g/L的人类相关暴露显着增加了心肌炎,并将雌性转化为雄性样炎症性。在这种BPA剂量下,心肌炎(使用全心脏的QRT-PCR)在心脏中的ER显着降低,而与对照组相比,ER显着增加,表明BPA在心脏中的ER信号传导不调。基于这些发现以及有关ER的心脏保护作用的文献,研究人员假设BPA通过肥大细胞上的ER增加了雌性小鼠的心肌炎。研究人员将通过在AIM 1中确定成年人对BPA的暴露是否通过ER(或其他ERS)来研究BPA对心肌炎和DCM的影响,以增加成年男性和雌性小鼠的心肌炎,以及通过检查BPA对BPA对BPA对男性和女性雌性的影响(F1)的作用。如果BPA激活肥大细胞以增加ICVD,则该研究将对对疾病发病机理的理解产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DeLisa Fairweather其他文献
DeLisa Fairweather的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DeLisa Fairweather', 18)}}的其他基金
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
线粒体细胞外囊泡在不同性别的 CVB3 心肌炎中的作用
- 批准号:
10644008 - 财政年份:2022
- 资助金额:
$ 24.3万 - 项目类别:
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
线粒体细胞外囊泡在不同性别的 CVB3 心肌炎中的作用
- 批准号:
10852725 - 财政年份:2022
- 资助金额:
$ 24.3万 - 项目类别:
Sex differences in exercise-induced mitochondrial function during viral myocarditis
病毒性心肌炎期间运动诱发的线粒体功能的性别差异
- 批准号:
10227233 - 财政年份:2020
- 资助金额:
$ 24.3万 - 项目类别:
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)
脂肪源性生物纳米颗粒治疗心肌炎/扩张型心肌病(MPDPI)
- 批准号:
10089412 - 财政年份:2020
- 资助金额:
$ 24.3万 - 项目类别:
Role of viral mitophagosomes in driving sex differences in myocarditis
病毒线粒体吞噬体在心肌炎性别差异中的作用
- 批准号:
9764769 - 财政年份:2019
- 资助金额:
$ 24.3万 - 项目类别:
Role of viral mitophagosomes in driving sex differences in myocarditis
病毒线粒体吞噬体在心肌炎性别差异中的作用
- 批准号:
9892954 - 财政年份:2019
- 资助金额:
$ 24.3万 - 项目类别:
Endocrine disruptors effect on inflammatory heart disease
内分泌干扰物对炎症性心脏病的影响
- 批准号:
9268276 - 财政年份:2014
- 资助金额:
$ 24.3万 - 项目类别:
Sex Differences in Complement during Myocarditis/DCM
心肌炎/扩张型心肌病期间补体的性别差异
- 批准号:
8370119 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
Sex Differences in Complement during Myocarditis/DCM
心肌炎/扩张型心肌病期间补体的性别差异
- 批准号:
8896850 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
Sex Differences in Complement during Myocarditis/DCM
心肌炎/扩张型心肌病期间补体的性别差异
- 批准号:
9270289 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Modulation of Lifespan and Healthspan by Meiosis Genes
减数分裂基因对寿命和健康寿命的调节
- 批准号:
10724491 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Social and behavioral determinants of MOUD utilization and opioid overdose
MOUD 使用和阿片类药物过量的社会和行为决定因素
- 批准号:
10664099 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
The Effectiveness of Public Policy Interventions in Reducing Racial Disparities in Drowning: Lifeguard Certification, Pool Regulations, and Swimming Instruction Programs
公共政策干预措施在减少溺水种族差异方面的有效性:救生员认证、泳池规定和游泳指导计划
- 批准号:
10647460 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Gene regulatory mechanisms connecting metabolism and Alzheimer’s Disease
连接新陈代谢和阿尔茨海默病的基因调控机制
- 批准号:
10660149 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别: